Zhejiang Nhu Co Ltd (002001)
Shenzhen Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 26.19 |
|---|---|
| 52-week range | 22.35 – 39.14 |
| Return, 1 month / 3 months | −3.6% / −9.1% |
| Return, 1 year / 3 years | +14.4% / +79.2% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 37.5% |
| Worst drawdown (1 year) | -33.8% |
| Average daily value traded | 789.51M CNY |
| Dividend yield | 3.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zhejiang Nhu Co Ltd is a chemical company based in Zhejiang province in China. It makes vitamins, mainly vitamin E and vitamin A, along with carotenoids and related nutritional ingredients. The company also produces pharmaceutical intermediates and aroma chemicals. Its customers are feed, food and pharmaceutical manufacturers that use these ingredients in their own products, and it supplies them in bulk.
Zhejiang Nhu Co Ltd trades under the code 002001 on the Shenzhen Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zhejiang Nhu Co Ltd (002001) trades on the Shenzhen Stock Exchange in China. It last closed at CNY 26.19 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 366 of 2,821 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.4% and over the last three months it fell 9.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -11.4% | ||
| From 52-week high | -31.6% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.1% | ||
| 6-month return | -26.5% | ||
| 12-month return, skipping the last month | 18.7% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.8% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 789.51M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 78 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | −3.6% |
| 3 months | −9.1% |
| 6 months | −26.5% |
| 1 year | +14.4% |
| 3 years | +79.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 27.36 / 29.54 |
|---|---|
| Golden / death cross (60 days) | Death, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2026 | CNY 0.8000 |
| 20 Oct 2025 | CNY 0.2000 |
| 21 May 2025 | CNY 0.5000 |
| 22 Jan 2025 | CNY 0.2000 |
| 29 May 2024 | CNY 0.4500 |
| 14 Jun 2023 | CNY 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.